CDTX
Price
$19.18
Change
-$0.82 (-4.10%)
Updated
Apr 16 closing price
Capitalization
210.09M
IKT
Price
$1.98
Change
+$0.08 (+4.21%)
Updated
Apr 16 closing price
Capitalization
147.2M
Ad is loading...

CDTX vs IKT

Header iconCDTX vs IKT Comparison
Open Charts CDTX vs IKTBanner chart's image
Cidara Therapeutics
Price$19.18
Change-$0.82 (-4.10%)
Volume$57.1K
Capitalization210.09M
Inhibikase Therapeutics
Price$1.98
Change+$0.08 (+4.21%)
Volume$123.46K
Capitalization147.2M
CDTX vs IKT Comparison Chart
Loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDTX vs. IKT commentary
Apr 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDTX is a Buy and IKT is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 17, 2025
Stock price -- (CDTX: $19.18 vs. IKT: $1.98)
Brand notoriety: CDTX and IKT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDTX: 38% vs. IKT: 79%
Market capitalization -- CDTX: $210.09M vs. IKT: $147.2M
CDTX [@Biotechnology] is valued at $210.09M. IKT’s [@Biotechnology] market capitalization is $147.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $287.04B to $0. The average market capitalization across the [@Biotechnology] industry is $2.12B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDTX’s FA Score shows that 0 FA rating(s) are green whileIKT’s FA Score has 1 green FA rating(s).

  • CDTX’s FA Score: 0 green, 5 red.
  • IKT’s FA Score: 1 green, 4 red.
According to our system of comparison, CDTX is a better buy in the long-term than IKT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDTX’s TA Score shows that 6 TA indicator(s) are bullish while IKT’s TA Score has 4 bullish TA indicator(s).

  • CDTX’s TA Score: 6 bullish, 4 bearish.
  • IKT’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CDTX is a better buy in the short-term than IKT.

Price Growth

CDTX (@Biotechnology) experienced а +9.79% price change this week, while IKT (@Biotechnology) price change was +4.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.47%. For the same industry, the average monthly price growth was -15.91%, and the average quarterly price growth was -25.65%.

Reported Earning Dates

CDTX is expected to report earnings on Aug 13, 2024.

IKT is expected to report earnings on Nov 14, 2023.

Industries' Descriptions

@Biotechnology (+2.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDTX($210M) has a higher market cap than IKT($147M). CDTX YTD gains are higher at: -28.646 vs. IKT (-39.077). IKT has higher annual earnings (EBITDA): -20.04M vs. CDTX (-175.87M). CDTX has more cash in the bank: 190M vs. IKT (3.24M). IKT has less debt than CDTX: IKT (145K) vs CDTX (3.58M). CDTX has higher revenues than IKT: CDTX (1.28M) vs IKT (0).
CDTXIKTCDTX / IKT
Capitalization210M147M143%
EBITDA-175.87M-20.04M878%
Gain YTD-28.646-39.07773%
P/E RatioN/AN/A-
Revenue1.28M0-
Total Cash190M3.24M5,857%
Total Debt3.58M145K2,466%
FUNDAMENTALS RATINGS
CDTX: Fundamental Ratings
CDTX
OUTLOOK RATING
1..100
84
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CDTXIKT
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 29 days ago
84%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
View a ticker or compare two or three
Ad is loading...
CDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IKT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSLIX15.14N/A
N/A
Goldman Sachs Large Cap Value Instl
LYRNX12.25N/A
N/A
Lyrical International Value Equity Inv
GIRLX13.09N/A
N/A
Goldman Sachs Intl Sm Cp Insghts Inv
JHJCX20.07N/A
N/A
JHancock ESG Large Cap Core C
SPMHX8.49N/A
N/A
Invesco SteelPath MLP Alpha R5

CDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDTX has been closely correlated with BPTSY. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if CDTX jumps, then BPTSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDTX
1D Price
Change %
CDTX100%
-4.10%
BPTSY - CDTX
92%
Closely correlated
N/A
IVVD - CDTX
36%
Loosely correlated
-8.31%
CPRX - CDTX
35%
Loosely correlated
-4.48%
CABA - CDTX
33%
Poorly correlated
-3.57%
TRAW - CDTX
30%
Poorly correlated
-6.57%
More

IKT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IKT has been loosely correlated with CRGX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if IKT jumps, then CRGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IKT
1D Price
Change %
IKT100%
+4.21%
CRGX - IKT
39%
Loosely correlated
+1.98%
VERV - IKT
33%
Poorly correlated
-9.26%
KRYS - IKT
28%
Poorly correlated
-2.62%
IDYA - IKT
28%
Poorly correlated
-4.71%
CDTX - IKT
27%
Poorly correlated
-4.10%
More